Queries on Rilonacept in COVID-19 and Vaccine-Linked Pericarditis: Addressing Study Outcomes.
作者信息
Albulushi Arif, Al-Jabri Adil, Al-Amri Amir
机构信息
Department of Adult Cardiology, National Heart Center, The Royal Hospital, Muscat, Oman.
出版信息
CJC Open. 2024 May 1;6(8):1032. doi: 10.1016/j.cjco.2024.04.009. eCollection 2024 Aug.
Abstract
摘要
相似文献
1
Queries on Rilonacept in COVID-19 and Vaccine-Linked Pericarditis: Addressing Study Outcomes.
CJC Open. 2024 May 1;6(8):1032. doi: 10.1016/j.cjco.2024.04.009. eCollection 2024 Aug.
2
Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension.
CJC Open. 2024 Mar 4;6(6):805-810. doi: 10.1016/j.cjco.2024.02.002. eCollection 2024 Jun.
3
Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis.
Cureus. 2022 Nov 8;14(11):e31226. doi: 10.7759/cureus.31226. eCollection 2022 Nov.
4
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.
J Am Heart Assoc. 2024 Mar 19;13(6):e032516. doi: 10.1161/JAHA.123.032516. Epub 2024 Mar 12.
5
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial.
Heart. 2020 Nov 23;107(6):488-96. doi: 10.1136/heartjnl-2020-317928.
6
Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY.
J Am Heart Assoc. 2022 Oct 18;11(20):e023252. doi: 10.1161/JAHA.121.023252. Epub 2022 Oct 17.
7
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
Heart. 2023 Jan 27;109(4):297-304. doi: 10.1136/heartjnl-2022-321328.
8
Rilonacept use in lupus pericarditis.
Clin Exp Rheumatol. 2024 May;42(5):1115-1117. doi: 10.55563/clinexprheumatol/pb3hzb. Epub 2024 Mar 19.
9
Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.
Ann Pharmacother. 2022 May;56(5):572-581. doi: 10.1177/10600280211036499. Epub 2021 Aug 28.
10
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
N Engl J Med. 2021 Jan 7;384(1):31-41. doi: 10.1056/NEJMoa2027892. Epub 2020 Nov 16.
本文引用的文献
1
Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension.
CJC Open. 2024 Mar 4;6(6):805-810. doi: 10.1016/j.cjco.2024.02.002. eCollection 2024 Jun.
2
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):625-629. doi: 10.2459/JCM.0000000000001059.
3
Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment.
J Am Coll Cardiol. 2016 Nov 29;68(21):2311-2328. doi: 10.1016/j.jacc.2016.07.785.
Zotero 插件